Early Detection of Autism Spectrum Disorder
-
Speaker : CELINE SAULNIER
-
When : Wednesday, August 06, 2025
-
Time : 01 : 00 PM EST
-
Add To Calendar
Refer a Friend
Dr. Saulnier obtained her doctorate in Clinical Psychology from the University of Connecticut. She trained and worked at the Yale Child Study Center’s Autism Program for nearly a decade where she specialized in diagnostic assessment for ASD. In 2011, she relocated to Emory University School of Medicine and the Marcus Autism Center in Atlanta, GA, where she directed a large-scale clinical research program. In 2018, she opened her own company, Neurodevelopmental Assessment & Consulting Services, where she specializes in diagnostic assessment, as well as teaching and training for autism spectrum and related conditions. Dr. Saulnier has published over 50 articles, written two books, and she is an author on the Vineland Adaptive Behavior Scales, Third Edition.
Currently, the average age of ASD diagnosis in the United States is 4 years. Yet, ASD can be reliably diagnosed prior to age 2 years. This presentation will identify the earliest markers of ASD in infancy and toddlerhood, how to detect and diagnose ASD effectively, and how to rule out non-ASD neurodevelopmental disorders with overlapping symptoms. The use of evidence-based biomarkers for assisting in the diagnosis of ASD will also be discussed.
Areas Covered
- Define the diagnostic criteria for ASD and how these criteria apply to infants and toddlers
- Identify early markers of ASD in infants and toddlers
- Discuss an FDA-approved eye-tracking biomarker used to assist in the diagnosis of ASD
- Differentiate ASD from non-autism developmental delays in young children
Who Should Attend
Psychologists, Counselors, Psychiatrists, Pediatricians, daycare providers, preschool teachers, Speech Pathologists, Occupational and Physical Therapists
Why Should You Attend
Given that the current prevalence rate for Autism Spectrum Disorder is 1 in 31 children in the US, every practitioner who is working with young children needs to be knowledgeable of the risk signs for ASD. This includes parents, daycare providers, preschool teachers, pediatricians, nurse practitioners, physicians, special educators, psychologists, counselors, speech pathologists, occupational and physical therapists, and beyond. Research shows that early detection and intervention result in the best outcome and, therefore, nobody should be taking a ”wait-and-see” approach to presenting concerns. This workshop will provide an overview of the earliest risk signs for ASD during the first year of life, how to identify and detect symptoms early on, and the components to a comprehensive diagnostic evaluation. Evidence-based practices, including a new FDA-approved eye-tracking biomarker that detects ASD in toddlers, will be discussed.
-
$160.00
-
